Who owns Celldex Therapeutics?

Key details on Celldex Therapeutics (Ticker: CLDX)

Who owns Celldex Therapeutics?

Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 14.80M $232.01M Dec. 31, 2015
Franklin Resources 9.80M $153.74M Dec. 31, 2015
OppenheimerFunds 8.90M $139.58M Dec. 31, 2015
First Trust Advisors 7.42M $116.41M Dec. 31, 2015
Vanguard 6.79M $107.03M Dec. 31, 2015
Columbia Wanger Asset Management 3.61M $56.60M Dec. 31, 2015
BlackRock Fund Advisors 3.59M $56.22M Dec. 31, 2015
S.A.C. Capital Advisors 3.51M $84.89M Dec. 31, 2013
STATE STREET CORPORATION 3.31M $51.86M Dec. 31, 2015
Jennison Associates 3.03M $39.24M Sept. 30, 2014
LORD, ABBETT & CO 2.67M $48.72M Dec. 31, 2014
HealthCor Management 2.50M $8.88M June 30, 2011
SUSQUEHANNA INTERNATIONAL 2.49M $32.31M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.41M $37.75M Dec. 31, 2015
Frontier Capital Management 2.34M $36.62M Dec. 31, 2015
Sectoral Asset Management 2.23M $53.93M Dec. 31, 2013
Columbus Circle Investors 2.19M $53.00M Dec. 31, 2013
TimesSquare Capital Management 2.11M $38.52M Dec. 31, 2014
Millennium Management 2.07M $57.70M March 31, 2015
OrbiMed Advisors 2.06M $37.64M Dec. 31, 2014
HealthCor Management 2.00M $23.16M March 31, 2013
Redmile 1.95M $20.60M Sept. 30, 2015

Who sold Celldex Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ridgeback Capital Investments Dec. 31, 2012 3.80M $25.53M